NHMRC Clinical Trials and Cohorts Studies Grants
| Status | OPEN The Macquarie University Process from Grant Development to Submission Please note this application will be submitted via the NHMRC's new Grant Management System Sapphire. If you had an active RGMS account your CV and Profile email was migrated into Sapphire on 12 February 2020. To login to Sapphire: 1. If you have an existing RGMS account, a Sapphire account has been created for you. Click here to Activate your account. Tutorial and training modules for Sapphire can be found here. |
|---|---|
| Changes to DVCR Co-Funding | For NHMRC grants applicants will now be required to submit a formal DVCR Co-funding request. The formal DVCR Co-funding request replaces the previous support of the Strategic Research Fund (SRF), which was managed directly between your Faculty Research Office and the DVCR Office and was not directly visible to academics as internal co-funding for their successful grants. The DVCR Co-funding is to support MQ researchers to successfully complete their proposed NHMRC projects by providing up to 20% co-funding on funds to remain at Macquarie. The goal is for the DVCR Co-funding is to facilitate MQ applicants in providing a ‘top-up’ of NHMRC salary costs (PSP’s), which are lower than MQ equivalent salary rates. These changes align the principles of DVCR Co-funding with other external funding schemes and assist the University in rationalising the allocation of internal funding used to leverage competitive, external funding opportunities. As Macquarie researchers continue to excel in the NHMRC funding scheme, we need to find a mechanism to ensure all successful NHMRC grants can be supported. As context, since 2015, our application volume for NHMRC funding has nearly doubled year on year. We know that health and medical researchers at Macquarie will be more active than ever in the coming years in applying for NHMRC funding to support their research, hence the need to make changes to meet the growing volume of awards. Eligibility for DVCR Co-Funding Eligibility for the DVCR Co-Funding Scheme is now contingent upon on-time submission of grant applications by your mandatory compliance and eligibility check. Many applications for external funding require cash and in-kind contributions from the host institution in order to be considered for funding. This funding includes project support funds, funding for research associates, scholarships, and major equipment and in most cases is processed via the DVCR Co-Funding scheme. View further information on deadlines, processes and FAQs
|
| Aim | The objective of the Clinical Trials and Cohort Studies Grants 2022 opportunity is to support high quality clinical trials and cohort studies that address important gaps in knowledge, leading to relevant and implementable findings for the benefit of human health. This grant opportunity is open to research proposals for clinical trials and/or cohort studies of any size – that is, they may be large or small clinical trials or cohort studies. Please note that the Clinical Trials and Cohort Studies Grants scheme is not intended to provide ongoing support from NHMRC and grant funding does not support infrastructure costs. Grantees will be required to report against milestones at twelve-month intervals. The desired outcomes of the Clinical Trials and Cohort Studies Grant opportunity are improvements in health and well-being, health care practice or policy, as a result of:
A Clinical Trials and Cohorts Studies Grants can be requested for between one and five years depending on the proposal. |
| Assessment Criteria | Applications for Clinical Trials and Cohort Studies Grants are assessed by peers on the extent to which the application meets the scheme objectives. Applications will be assessed against the assessment criteria listed below. In addressing the assessment criteria, applicants should consider how the proposal addresses the associated points. 1. Significance (40%) Significance for this grant opportunity is the extent to which the research findings will substantially advance knowledge to improve the prevention, diagnosis or treatment of medical conditions, or to improve health and wellbeing. 2. Research quality (40%) Research quality for this grant opportunity encompasses the quality and feasibility of the proposed research, incorporating theoretical concepts, hypothesis, research design and robustness. 3. Team quality and capability (20%) This criterion is used to assess whether the CI team named in your application has the appropriate mix of research skills and experience to undertake the clinical trial and/or cohort study and achieve the stated objectives of the proposed research. Applications are assessed relative to opportunity, taking into consideration any career disruptions and recognising applicants’ industry-relevant expertise, where applicable It is recognised that Aboriginal and Torres Strait Islander applicants often make additional valuable contributions to policy development, clinical/public health leadership and/or service delivery, community activities and linkages, and are often representatives on key committees. If applicable, these contributions will be considered when assessing research output and track record. |
| Funding | The provisional funding allocation for the Clinical Trials and Cohort Studies Grants 2019 opportunity is estimated to be up to $70 million. NHMRC’s Research Committee annually reviews and recommends indicative budget amounts to be awarded across individual funding schemes. The amount of funding for a Clinical Trials and Cohort Studies Grant will be based on assessment of the requested budget. Applications must clearly justify the requested duration and budget, and how they will support the proposed outcomes of the research. Peer reviewers will consider this information and may reduce the duration and/or budget to ensure the research aims and objectives can be achieved while ensuring value with money. |
| Faculty Processes | Guide for NHMRC Applicants on Macquarie Approvals Process Through PURE The Faculties have their own approval and review processes for grants under this scheme. They may also have deadlines for submission of draft applications that are earlier than Research Services deadlines. Please ensure that you contact your Faculty, as early as possible, for information on process and deadlines. Faculty contacts: Faculty of Medicine, Health and Human Sciences Faculty of Science and Engineering Macquarie Business School Faculty of Arts |
| Key Dates | Note: NHMRC locates all their Scheme documentation in GrantConnect. You will be required to set-up a username and password to access. For applications submitted in 2023: Please note that our grant review processes have changed. Strategic reviews are optional, while compliance and eligibility checks are mandatory. If you wish to receive a strategic review of your NHMRC application, you must book via the online booking calendar. Compliance and eligibility reviews for your NHMRC application is mandatory and you must book via the online booking calendar. There are sufficient booking times available for all applicants, but we recommend booking early to ensure you have an ample choice of dates. These are estimated dates from previous NHMRC rounds but are subject to change 2023 Round 1
|
| Resources | Note: NHMRC locates all their Scheme documentation in GrantConnect. You will be required to set-up a username and password to access. Notification Of Intent (NOI) NHMRC Information NHMRC DVCR Co-Funding Request Form CERTIFICATIONS WORKSHOPS Introduction to the NHMRC Clinical Trials and Cohorts Studies (CTCS) Grant Funding Scheme NHMRC Clinical Trials and Cohorts Studies (CTCS) Grant Funding Scheme Building your Budget for the NHMRC Clinical Trials and Cohorts Studies (CTCS) Grant and Ideas Grant Schemes |
| Contacts | Grant Development Team |